FH and nonpapillary renal cell carcinoma: Most treatment stratigies for patients with FH-deficient RCC are quite similar to the treatment guidelines for patients withccRCC; however, due to the different pathogenesis and oncologic behavior, treatments that mimic ccRCC often result in an increased chance of distant metastasis and death for patients with FH-deficient RCC [53].